Institute of Human Behavioral Medicine, Seoul National University College of Medicine, Seoul 110-744, Republic of Korea.
BMC Psychiatry. 2013 Oct 8;13:251. doi: 10.1186/1471-244X-13-251.
Foulds' Delusions-Symptoms-State Inventory (DSSI) has been purported to be a reliable, systematic categorical measure to assess the patients with schizophrenia according to the degree of illness. However, further cross-validations using other clinical measures and diverse samples from other cultures have not been advanced recently. We aimed to examine the validity of the DSSI hierarchical class model using both Korean non-patient and patient (schizophrenia and depression) groups.
The hypothesis of inclusive, non-reflexive relationships among the DSSI classes was tested. The power of DSSI to detect presence of symptoms was assessed via cross-validation with other clinical measures, and the differences between the clinical features among the DSSI classes were examined using the Minnesota Multiphasic Personality Inventory (MMPI).
The high rate of model conformity (91.1%) across the samples and cross-validation with other criterion measures provided further support for the validity of DSSI.
DSSI is a reliable self-report measure that can be applied to both patient and non-patients to assess the presence and severity of psychiatric illness. Future studies that include more diverse clinical groups are necessary to lend further support for its utility in clinical practice.
福尔德错觉-症状-状态量表(DSSI)据称是一种可靠的、系统的分类测量工具,可根据疾病程度评估精神分裂症患者。然而,最近没有使用其他临床测量方法和来自其他文化的不同样本进行进一步的交叉验证。我们旨在使用韩国非患者和患者(精神分裂症和抑郁症)群体来检验 DSSI 层次类别模型的有效性。
检验了 DSSI 类之间包含性、非反射性关系的假设。通过与其他临床测量方法的交叉验证来评估 DSSI 检测症状存在的能力,并使用明尼苏达多相人格问卷(MMPI)检查 DSSI 类别之间的临床特征差异。
样本之间以及与其他标准测量方法的交叉验证中模型一致性的高比率(91.1%)为 DSSI 的有效性提供了进一步的支持。
DSSI 是一种可靠的自我报告测量工具,可用于评估患者和非患者的精神疾病的存在和严重程度。需要进行更多样化的临床群体研究,以进一步支持其在临床实践中的效用。